1-3 of 3
Hege Froen
Close
Sort by
Journal Articles

Arterial Thromboembolism in Cancer Patients Treated with Apixaban

Trine-Lise Larsen, Jorunn Brekke, Herish Garresori, Hege Frøen, Eva-Marie Jacobsen, Dag Torfoss, Hilde Skuterud Wik, Tone Ronnaug Enden, Alina Carmen Porojnicu, Petter Quist-Paulsen, Elin Velle, Per Morten Sandset, Anne Hansen Ree, Anders E.A. Dahm
Journal: Blood
Blood (2022) 140 (Supplement 1): 11366–11367.
https://doi.org/10.1182/blood-2022-160363
Published: 2022
Journal Articles

Low Dose Apixaban As Secondary Prophylaxis for Venous Thromboembolism in Cancer Patients, 30 Months Follow-up

Trine-Lise Hannevik, Herish Garresori, Jorunn Brekke, Tone Ronnaug Enden, Hege Froen, Eva-Marie Jacobsen, Petter Quist-Paulsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders EA Dahm
Journal: Blood
Blood (2021) 138 (Supplement 1): 3231.
https://doi.org/10.1182/blood-2021-148105
Published: 2021
Journal Articles

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Ulla Randen, Tor Henrik Anderson Tvedt, Bruno Fattizzo, Einar Haukås, Megan Kell, Robert Brudevold, Anders E. A. Dahm, Jakob Dalgaard, Hege Frøen, Randi Fykse Hallstensen, Pernille H. Jæger, Henrik Hjorth-Hansen, Agnieszka Małecka, Markku Oksman, Jürgen Rolke, Mallika Sekhar, Jon Hjalmar Sørbø, Eirik Tjønnfjord, Galina Tsykunova, Geir E. Tjønnfjord
Journal: Blood
Blood (2020) 136 (4): 480–488.
https://doi.org/10.1182/blood.2020005674
Published: 2020
Includes: Supplemental data